|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Goodwill and long-lived asset impairments | |||||
| Share-based compensation | |||||
| Noncash interest expense (income), net | |||||
| Net (gain) loss on investment activity and other | |||||
| Deferred income taxes | |||||
| Changes in operating assets and liabilities, net of effects of acquisitions and divestitures: | |||||
| Current and noncurrent receivables, net | |||||
| Film and television costs, net | |||||
| Accounts payable and accrued expenses related to trade creditors | |||||
| Other operating assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Capital expenditures | |||||
| Cash paid for intangible assets | |||||
| Construction of Universal Beijing Resort | |||||
| Acquisitions, net of cash acquired | |||||
| Proceeds from sales of businesses and investments | |||||
| Advance on sale of investment | |||||
| Purchases of investments | |||||
| Other | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing Activities | |||||
| Proceeds from (repayments of) short-term borrowings, net | |||||
| Proceeds from borrowings | |||||
| Repurchases and repayments of debt | |||||
| Repayment of collateralized obligation | |||||
| Repurchases of common stock under repurchase program and employee plans | |||||
| Dividends paid | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Impact of foreign currency on cash, cash equivalents and restricted cash | |||||
| Increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
Loading...